Talfirastide (Standard)

O=C(N(CCC1)[C@@H]1C(O)=O)[C@@H](NC([C@@]([C@@H](C)CC)([H])NC([C@@H](NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](N)CC(O)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)=O)CC3=CNC=N3

[1]Gómez-Mendoza DP, et al. Angiotensin- (1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4. J Proteomics. 2019;208:103486.|[2]Li P, et al. Angiotensin- (1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997 Jan;29 (1 Pt 2) :394-400.|[3]Khajah MA, et al. Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis. PLoS One. 2016 Mar 10;11 (3) :e0150861.|[4]Alzayadneh EM, et al. Angiotensin- (1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2. Cell Signal. 2014 Sep 19. pii: S0898-6568 (14) 00314-3.|[5]Janatpour ZC, et al. Subcutaneous Administration of Angiotensin- (1-7) Improves Recovery after Traumatic Brain Injury in Mice. J Neurotrauma. 2019;36 (22) :3115-3131.